Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Kimberly-Clark has finalized a $40 billion acquisition of Tylenol maker Kenvue, restructuring the global consumer health and wellness landscape.
7 trends tracked about this subject — the full history, oldest to newest below.
Kimberly-Clark has finalized a $40 billion acquisition of Tylenol maker Kenvue, restructuring the global consumer health and wellness landscape.
Earth.com reports a scientific study linking prenatal exposure to a common painkiller with developmental changes in baby girls.
An observational study examines prenatal paracetamol exposure and links it to altered reproductive development in daughters.
New research suggests prenatal Tylenol exposure may be linked to reproductive changes in daughters.
Scientists warn of a nearly 400% increase in toxic liver injuries linked to common medications and supplements, according to poison center data.
The US FDA has approved the first over-the-counter combination of acetaminophen and naproxen sodium for extended pain relief.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.